Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis

NCT02133664 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT02133664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02133664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
Lead sponsor
Oregon Health and Science University
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2014
Completion date
May 31, 2016
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognition, multiple sclerosis